Contact Share

Digital health

Digital technology as an accelerator

The future of access to healthcare is mobile

In most Western countries, solid solidarity mechanisms have been the foundation for our prosperity.  This solidarity took us over 100 years to build. Today, digital technology offers huge opportunities to bring healthcare within reach of people who, until now, were structurally excluded. And we can do it more efficiently and at an unprecedented pace.

The mobile phone is one of the biggest social equalizers on the continent. More than 90% of people use a simple mobile phone. This offers huge opportunities to develop new forms of pre-payment and risk pooling, and to tackle Africa’s poor health statistics.

Using a live test to implementation approach the mHealth lab, which has been experimenting with mobile solutions since 2013, has resulted in many viable healthcare solutions going from invent to full implementation.  Including M-TIBA.

M-TIBA: connecting patients, payers and providers

M-TIBA is a platform for financial inclusion in healthcare. It not only empowers consumers, but also improves financial protection, supports better quality of care and generates local and international financing for health.

M-TIBA enables people to save, send, receive and pay money for medical treatment through a mobile health wallet on their phone. It’s a closed loop with conditional funds that can only be spent on healthcare at selected providers.

M-TIBA is accelerating our mission to make health markets work by:

  • Boosting demand. It connects the poor, living in urban slums and rural areas, to savings schemes, benefits and risk pooling opportunities at very low costs. We are channeling demand to selected networks of healthcare providers.
  • Stimulating supply. Digital payments minimize leakages and enhance efficiency. We are also strengthening cost-efficiency of service delivery through mechanisms like joint procurement systems, access to finance or capacity building through e-learning.
  • Generating more funds for health. It’s increasing transparency and reducing risk and transaction costs, making it more attractive to invest in health. This helps to crowd in funding from solidarity payers like family members, employers, donors, or governments, who receive proof that their money is used for healthcare only.

 

M-TIBA in action

“Previously I never used to save for healthcare. Every time I got sick I would either stay home or maybe borrow from friends. I mostly use M-TIBA for my kids treatment. These days if my children show any symptoms, I bring them to hospital without any delay. M-TIBA has completely changed my life”

– Agnes Anyango, M-TIBA user

Latest news about mHealth

Joep Lange Institute hosts evening with Dan Ariely at De Balie

We all know that companies like Facebook and Google analyze our behavior to sell ads. Why can’t we use this approach and develop social innovations to help people live healthier lives? Read more

Jun 21, 2017 news
Peer2peer healthcare financing platform HealthConnect launched

HealthConnect is a digital platform for mobile-to-mobile transactions for healthcare in Africa. Her Royal Highness Princess Mabel van Oranje completed the first HealthConnect transaction ahead of the official launch at the 25th AmsterdamDiner on Saturday 17 June 2017. With just a few clicks, she demonstrated how simple it is for any individual to directly pay for the basic healthcare needs of a Kenyan family. Read more

Jun 19, 2017 news
M-TIBA wins 2017 Financial Times/IFC Transformational Business Award

We are very proud to announce that M-TIBA, represented by CarePay, has received the FT/IFC Transformational Business Award in the category Achievement in Sustainable Development, with a focus on Health, Wellness and Disease Prevention. This was presented during an FT/IFC award ceremony in London on Thursday, 8th June 2017. Read more

Jun 09, 2017 news

mHealth briefs

The PharmAccess Research briefs provide an overview, insights and background on several projects, or subject areas usually dealt with in long form researches conducted by PharmAccess and our partners.

MHEALTH BRIEF
MTIBA: A DONOR-FUNDED MOBILE HEALTH WALLET IN KENYA
View brief
MHEALTH BRIEF
M-CHAMA: A COMMUNALLY-FUNDED MOBILE HEALTH WALLET
View brief
MHEALTH BRIEF
SAVING ON A DIGITAL PLATFORM IN SLUM SCHOOLS IN NIGERIA
View brief

mHealth lab

invent | experiment | implement


Technology is advancing at an exponential rate, but our society has not succeeded in harnessing its full potential to make it work for those that need it the most. We believe that if it is adapted right, mobile technology plays a key role in improving access to quality and affordable healthcare for millions of citizens across the globe.

The mHealth Lab has positioned itself on the African continent as a live testing ground where innovations in mobile technology and healthcare financing complemented by insights from behavioral economics are brought right to the fingertips of the end users.

At the mHealth Lab we constantly generate new concepts (invent), test these concepts directly with users and optimize them to ensure their viability (experiment). Once proof of principle has been achieved, these viable healthcare solutions can be adapted in a myriad of settings (implement).

In collaboration with other frontrunners and experts we believe that we can play a significant role in the realization of African health systems that work for everyone.

Workflow

Each (disruptive) innovation starts with an idea that needs to be validated and fine-tuned before it can reach scale and sustainable impact. In the lab develop and test ideas using mobile technology that strengthen and accelerate PharmAccess integrated approach on both the demand and supply side of healthcare. This is our flow from idea to full scale implementation:

ourflow

Watch the most recent lab update on a test in the slums of Nairobi to move towards “cashless clinics”.

Interested in working with us or learning more about our mHealth activities?

AHTC, Tower 4C • Paasheuvelweg 25
1105 BP Amsterdam • The Netherlands

T: +31 (0) 20 – 210 3920
E: info@pharmaccess.org